Metraipolis › archive › dc_ed4ebb469e85
Risk stratification of ibrutinib toxicity co-administered with triazole antifungals: insights from real-world pharmacovigilance and clinical evidence — Europe PMC PMID:42741283
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42741283
- DOI
- 10.3389/fmed.2026.1875804
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T18:49:39.856Z
- SHA-256 of the archived text
fa3070a787ccfcadffa1244fff2aa80388e4ad22d9460c8b6ef31d5ca57677d3- Stable URL of this page
https://metraipolis.com/documento/dc_ed4ebb469e85
How to cite
Risk stratification of ibrutinib toxicity co-administered with triazole antifungals: insights from real-world pharmacovigilance and clinical evidence — Europe PMC PMID:42741283 — Europe PMC (en), https://europepmc.org/article/MED/42741283 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed4ebb469e85 (Metraipolis archive dc_ed4ebb469e85, sha256 fa3070a787ccfcadffa1244fff2aa80388e4ad22d9460c8b6ef31d5ca57677d3)
BibTeX
@misc{dced4ebb469e85,
title = {Risk stratification of ibrutinib toxicity co-administered with triazole antifungals: insights from real-world pharmacovigilance and clinical evidence — Europe PMC PMID:42741283},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42741283},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed4ebb469e85; sha256 fa3070a787ccfcadffa1244fff2aa80388e4ad22d9460c8b6ef31d5ca57677d3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42741283. Agents can read the archived copy with the MCP tool read_document.